StreetInsider.com News Articles

Revvity Inc (RVTY) PT Raised to $165 at KeyBanc

Fri, 04 Sep 2026 07:16:15 -0400

KeyBanc analyst Paul Knight raised the price target on Revvity Inc (NYSE: RVTY) to $165.00 (from $125.00) while maintaining a Overweight rating.

Revvity Inc (RVTY) PT Raised to $144 at Baird

Thu, 03 Sep 2026 07:06:22 -0400

Baird analyst Catherine Ramsey Schulte raised the price target on Revvity Inc (NYSE: RVTY) to $144.00 (from $131.00) while maintaining a Outperform rating.

RBC Capital Starts Revvity Inc (RVTY) at Sector Perform

Tue, 01 Sep 2026 02:44:09 -0400

RBC Capital analyst Dan Leonard initiates coverage on Revvity Inc (NYSE: RVTY) with a Sector Perform rating and a price target of $135.00.

The analyst comments: “We are initiating coverage of Revvity (RVTY) with a $135 price target and Sector Perform rating, which reflects the durability of high quality franchises across diagnostics and life sciences balanced against what we believe are structural challenges to Revvity's 6-8% long-term organic growth outlook. We could become more constructive on greater confidence in the growth outlook.

Revvity has been one of the most active portfolio managers in the Life Science Tools & Diagnostics industry. A series

RBC Capital Starts Revvity Inc (RVTY) at Sector Perform

Tue, 01 Sep 2026 02:44:09 -0400

RBC Capital analyst Dan Leonard initiates coverage on Revvity Inc (NYSE: RVTY) with a Sector Perform rating and a price target of $135.00.

Revvity has been one of the most active portfolio managers in the Life Science Tools & Diagnostics industry. A series

Form 4 REVVITY, INC. For: Aug 25 Filed by: MICHAS ALEXIS P

Tue, 25 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260825/26974657.html

Form 4 REVVITY, INC. For: Aug 14 Filed by: Goldberg Joel S

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944168.html

Form 4 REVVITY, INC. For: Aug 13 Filed by: Singh Prahlad R.

Mon, 17 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260817/26937945.html

Form SCHEDULE 13G/A REVVITY, INC. Filed by: T. Rowe Price Investment Management, Inc.

Fri, 14 Aug 2026 10:41:00 -0400

si-local-file:///var/storage/secattach/20260814/26926704.html

Form SCHEDULE 13G/A REVVITY, INC. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Fri, 14 Aug 2026 10:39:00 -0400

si-local-file:///var/storage/secattach/20260814/26926590.html

Form 10-Q REVVITY, INC. For: Jul 05

Tue, 11 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260811/26905679.html

Revvity to Present at Upcoming Investor Conferences

Tue, 11 Aug 2026 08:00:00 -0400

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:

Wells Fargo 21st Annual Healthcare Conference
Wednesday, September 9, 2026
8:45 a.m. ET - Prahlad Singh, president and chief executive officer

Morgan Stanley 24th Annual Global Healthcare Conference
Monday, September 14, 2026
8:30 a.m. ET - Max Krakowiak, senior vice president and chief financial officer

Baird’s 2026 Global Healthcare Conference
Tuesday, September 15, 2026
9:05 a.m. ET – Steve Willoughby, senior vice president, investor relations, ESG, and risk

Attendees will receive an update on the Company and its strategic priorities

Revvity to Present at Upcoming Investor Conferences

Tue, 11 Aug 2026 08:00:00 -0400

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:

Wells Fargo 21st Annual Healthcare Conference
Wednesday, September 9, 2026
8:45 a.m. ET - Prahlad Singh, president and chief executive officer

Morgan Stanley 24th Annual Global Healthcare Conference
Monday, September 14, 2026
8:30 a.m. ET - Max Krakowiak, senior vice president and chief financial officer

Baird’s 2026 Global Healthcare Conference
Tuesday, September 15, 2026
9:05 a.m. ET – Steve Willoughby, senior vice president, investor relations, ESG, and risk

Attendees will receive an update on the Company and its strategic priorities

Revvity Inc (RVTY) PT Raised to $110 at Stifel

Wed, 05 Aug 2026 11:15:35 -0400

(Updated - August 5, 2026 11:15 AM EDT)

Stifel analyst Daniel Arias raised the price target on Revvity Inc (NYSE: RVTY) to $110.00 (from $100.00) while maintaining a Hold rating.

The analyst commented, "Pro forma organic growth of 3% and adj. EPS of $1.41 topped guidance, although that includes $16M of tariff refunds and pulled forward tax savings were most of the beat. Dx remains the engine with an 11% organic growth qtr; whereas Life Science Solutions was only slightly positive, and Life Science overall declined 3% on a well telegraphed tough software comp. However, LS orders accelerated to end the quarter

Revvity Inc (RVTY) PT Raised to $110 at Stifel

Wed, 05 Aug 2026 11:15:35 -0400

(Updated - August 5, 2026 11:15 AM EDT)

Stifel analyst Daniel Arias raised the price target on Revvity Inc (NYSE: RVTY) to $110.00 (from $100.00) while maintaining a Hold rating.

Revvity Inc (RVTY) PT Raised to $120 at Bernstein SocGen Group

Wed, 05 Aug 2026 09:23:16 -0400

Bernstein SocGen Group analyst Eve Burstein raised the price target on Revvity Inc (NYSE: RVTY) to $120.00 (from $115.00) while maintaining a Market Perform rating.

Form 8-K REVVITY, INC. For: Aug 04

Tue, 04 Aug 2026 06:21:00 -0400

si-local-file:///var/storage/secattach/20260804/26860911.html

Revvity, Inc. (RVTY) Tops Q2 EPS by 20c; Offers Guidance

Tue, 04 Aug 2026 06:04:43 -0400

Revvity, Inc. (NYSE: RVTY) reported Q2 EPS of $1.41, $0.20 better than the analyst estimate of $1.21. Revenue for the quarter came in at $729.68 million versus the consensus estimate of $703.39 million.

GUIDANCE:

Revvity, Inc. sees FY2026 revenue of $2.83-2.86 billion, versus the consensus of $2.83 billion.

For earnings history and earnings-related data on Revvity, Inc. (RVTY) click here.

Revvity, Inc. (RVTY) Tops Q2 EPS by 20c; Offers Guidance

Tue, 04 Aug 2026 06:04:43 -0400

GUIDANCE:

Revvity, Inc. sees FY2026 revenue of $2.83-2.86 billion, versus the consensus of $2.83 billion.

For earnings history and earnings-related data on Revvity, Inc. (RVTY) click here.

Revvity Announces Financial Results for the Second Quarter of 2026

Tue, 04 Aug 2026 06:00:00 -0400

Revenue of $730 million; pro forma revenue of $711 million; 4% pro forma revenue growth; 3% pro forma organic revenue growth
GAAP EPS from continuing operations of $0.48; adjusted EPS from continuing operations of $1.41; GAAP pro forma EPS from continuing operations of $0.52; pro forma adjusted EPS from continuing operations of $1.41
Enters into definitive agreement to divest China Immunodiagnostics business
Raises full year guidance

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today reported financial results for the second quarter ended July 5, 2026.

The Company reported GAAP earnings per share from continuing operations of $0.48,

Revvity Announces Financial Results for the Second Quarter of 2026

Tue, 04 Aug 2026 06:00:00 -0400

Revenue of $730 million; pro forma revenue of $711 million; 4% pro forma revenue growth; 3% pro forma organic revenue growth
GAAP EPS from continuing operations of $0.48; adjusted EPS from continuing operations of $1.41; GAAP pro forma EPS from continuing operations of $0.52; pro forma adjusted EPS from continuing operations of $1.41
Enters into definitive agreement to divest China Immunodiagnostics business
Raises full year guidance

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today reported financial results for the second quarter ended July 5, 2026.

The Company reported GAAP earnings per share from continuing operations of $0.48,

Revvity (RVTY) Declares $0.07 Quarterly Dividend; 0.2% Yield

Fri, 31 Jul 2026 16:05:02 -0400

Revvity (NYSE: RVTY) declared a quarterly dividend of $0.07 per share, or $0.28 annualized.

The dividend will be payable on November 13, 2026, to stockholders of record on October 23, 2026, with an ex-dividend date of October 22, 2026.

The annual yield on the dividend is 0.2 percent.

For a dividend history and other dividend-related data on Revvity (RVTY) click here.

Revvity Board Declares Quarterly Dividend

Fri, 31 Jul 2026 16:05:00 -0400

WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on November 13, 2026 to all shareholders of record at the close of business on October 23, 2026.

About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus

Revvity Board Declares Quarterly Dividend

Fri, 31 Jul 2026 16:05:00 -0400

Form 4 REVVITY, INC. For: Jul 20 Filed by: Gonzales Anita

Wed, 22 Jul 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260722/26801618.html

Form 144 REVVITY, INC. Filed by: Gonzales Anita

Mon, 20 Jul 2026 09:40:00 -0400

si-local-file:///var/storage/secattach/20260720/26788061.html